What You Should Know:
- A new PwC report offers insights into how pharma companies can translate game-changing science into greater returns.
- Despite many major therapeutic advancements within the last decade, returns from pharma companies lagged the S&P 500 by about one-third and biotech underperformed by 60 percent. The stock performance divide between the front and back of the pack has been widening. PwC’s analysis showed that in 2021, the five-year
Read More
Pharma
3 Keys to Eliminating Data Breakdowns in Life Sciences
Across life sciences, experts boldly predict that data is the new currency—and that mobilizing data from clinical trials, wearable devices and even social media will ignite innovation in 2022. But leveraging data for innovation depends not just on data analytics, but also access to the right data and timely analysis.
As the amount of data that life sciences experts have at their fingertips explodes, with leaders tapping into real-world evidence from smartphone apps, wearable devices and
Read More
C2i Genomics Brings Distributed Cancer Monitoring to Cancer Centers Across Europe
What You Should Know:
- C2i Genomics, a cancer intelligence company launches its C2inform minimal residual disease (MRD) test across Europe, after obtaining CE-IVD marking in the EU, UK and Switzerland. The company also announced the completion of several clinical trials across the globe, including leading cancer centers in Europe, U.S. and Singapore.
- The new clinical data will be presented at the 2022 American Association for Cancer Research (AACR) annual meeting in New Orleans,
Read More
Doceree Lands $11M for Physician-Only Platform for Precision Marketing
What You Should Know:
- Doceree, a global network of HCP-only platforms for programmatic messaging raises $11M in a Series A funding round led by Eight Roads Ventures to enrich programmatic messaging offerings for health information technology (HIT) platforms to improve the distribution of hyper-relevant messages to prescribers. The round also included participation from F-Prime Capital and Alkemi Growth Capital.
-
Read More
Nurse-1-1 Raises $2.3M to Expand Conversational Marketing for Healthcare
What You Should Know:
- Nurse-1-1, the first conversational marketing company for healthcare raises $2.3M in seed funding round led by Argon Ventures with participation from York IE and Hyperplane.
- The company will use the financing to expand its team, accelerate its go-to-market efforts, and scale its current partnerships with publicly traded and nationwide digital health, at-home testing, and pharma companies.
Nationwide Nurse Work
Through a
Read More
VivoSense Raises $25M for Wearable Sensor Biomarkers to Advance Clinical Trials
What You Should Know:
- VivoSense, an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data raises $25 Million in Series A funding.
- The financing will accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. VivoSense will also use this financing to expand and refine its informatics platform for data analysis from wearable and connected technologies to deliver validated digital
Read More
physIQ, CellCarta Collaborate on Study to Revolutionize Vaccine
What You Should Know:
- Today, digital medicine leader physIQ and CellCarta, a global leader in precision medicine services announced they are collaborating on a groundbreaking study that could revolutionize vaccine development.
- The strategic collaboration advances the detailed study of early, individualized human responses to vaccinations as pharma companies race to deliver safe, effective vaccines sooner.
physIQ, a pioneer in digital medicine, and CellCarta, a global leader in
Read More
HIMSS22 Day 2 Roundup: Google Partners with MEDITECH, Microsoft’s Health Cloud Strategy Expansions
Mergers & Acquisitions (M&A) Activity
OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform
OptimizeRx, a provider of point-of-care technology solutions helping patients start and stay on therapy announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a provider in delivering end-to-end automation for specialty pharmaceutical transactions. The acquisition includes the full Market Access Management Platform
Read More
OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform
What You Should Know:
- OptimizeRx, a provider of point-of-care technology solutions helping patients start and stay on therapy announced a definitive agreement to acquire the EvinceMed platform and related assets. Financial details were not disclosed.
- EvinceMed is a provider in delivering end-to-end automation for specialty pharmaceutical transactions. The acquisition includes the full Market Access Management Platform supporting pharma manufacturers, hub providers and pharmacies to
Read More
BrightInsight & UCB Partner to Build Digital Care Solutions for Rare Diseases
What You Should Know:
- BrightInsight, provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced a partnership with global biopharma, UC to build digital care solutions for rare diseases.
- BrightInsight will build and bring to market a digital disease management solution to support patients with Myasthenia Gravis (MG), a rare autoimmune disease that disrupts how nerves communicate with muscles, affecting more than 700,000 people
Read More
